返回
PharmVar GeneFocus: CYP4F2
DOI:10.1002/cpt.3405.png)
摘要
En 中文
The Pharmacogene Variation Consortium (PharmVar) serves as a global repository providing star (*) allele nomenclature for the polymorphic human CYP4F2 gene. CYP4F2 genetic variation impacts the metabolism of vitamin K, which is associated with warfarin dose requirements, and the metabolism of drugs, such as imatinib or fingolimod, and certain endogenous compounds including vitamin E and eicosanoids. This GeneFocus provides a comprehensive overview and summary of CYP4F2 genetic variation including the characterization of 14 novel star alleles, CYP4F2*4 through *17. A description of how haplotype information cataloged by PharmVar is utilized by the Pharmacogenomics Knowledgebase (PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC) is also provided.
Keyword:
B-4 OMEGA-HYDROXYLASE
MAINTENANCE DOSE REQUIREMENT
NONGENETIC FACTORS
ARACHIDONIC-ACID
COMMON VARIANTS
HUMAN LIVER
ACENOCOUMAROL
POLYMORPHISMS
EXPRESSION
ASSOCIATION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
C
IF:
5.5
论文数:
8.6K
被引数:
1.9W
机构
引用论文
Looping variation observed in environmental gamma-ray measurement due to atmospheric radon daughters
Vitamin K-dependent carboxylation of coagulation factors: insights from a cell-based functional study
HAEMATOLOGICA
IF7.9

